| Enhancing Few-Shot Learning with Integrated Data and GAN Model Approaches | Nov 25, 2024 | Data AugmentationDrug Discovery | —Unverified | 0 | 0 |
| Application and Assessment of Deep Learning for the Generation of Potential NMDA Receptor Antagonists | Mar 31, 2020 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Enhancing Drug Discovery: Autoencoder-Based Latent Space Augmentation for Improved Molecular Solubility Prediction using LatMixSol | May 30, 2025 | Drug DiscoveryFeature Compression | —Unverified | 0 | 0 |
| Enhancing Chemical Reaction and Retrosynthesis Prediction with Large Language Model and Dual-task Learning | May 5, 2025 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| Causal inference in drug discovery and development | Sep 29, 2022 | Causal InferenceDecision Making | —Unverified | 0 | 0 |
| Energy-based View of Retrosynthesis | Jul 14, 2020 | Drug DiscoveryRetrosynthesis | —Unverified | 0 | 0 |
| A Point Cloud-Based Deep Learning Strategy for Protein-Ligand Binding Affinity Prediction | Jul 9, 2021 | Drug DiscoveryProtein-Ligand Affinity Prediction | —Unverified | 0 | 0 |
| A Graph-in-Graph Learning Framework for Drug-Target Interaction Prediction | Jul 15, 2025 | Drug DiscoveryGraph Learning | —Unverified | 0 | 0 |
| Energy-based Generative Models for Target-specific Drug Discovery | Dec 5, 2022 | Drug Discovery | —Unverified | 0 | 0 |
| CASTELO: Clustered Atom Subtypes aidEd Lead Optimization -- a combined machine learning and molecular modeling method | Nov 27, 2020 | BIG-bench Machine LearningClustering | —Unverified | 0 | 0 |
| EndToEndML: An Open-Source End-to-End Pipeline for Machine Learning Applications | Mar 27, 2024 | Drug Discovery | —Unverified | 0 | 0 |
| End-to-end learning of pharmacological assays from high-resolution microscopy images | May 1, 2019 | Cell SegmentationDrug Discovery | —Unverified | 0 | 0 |
| A photonic chip-based machine learning approach for the prediction of molecular properties | Mar 3, 2022 | BIG-bench Machine LearningComputational chemistry | —Unverified | 0 | 0 |
| Enabling Regional Explainability by Automatic and Model-agnostic Rule Extraction | Jun 25, 2024 | Drug Discovery | —Unverified | 0 | 0 |
| CardiGraphormer: Unveiling the Power of Self-Supervised Learning in Revolutionizing Drug Discovery | Jul 3, 2023 | Drug DiscoverySelf-Supervised Learning | —Unverified | 0 | 0 |
| Can Pre-trained Models Really Learn Better Molecular Representations for AI-aided Drug Discovery? | Aug 21, 2022 | Drug Discovery | —Unverified | 0 | 0 |
| A Perspective on AI-Guided Molecular Simulations in VR: Exploring Strategies for Imitation Learning in Hyperdimensional Molecular Systems | Sep 11, 2024 | Drug DesignDrug Discovery | —Unverified | 0 | 0 |
| A Graph Completion Method that Jointly Predicts Geometry and Topology Enables Effective Molecule Assembly | May 27, 2025 | DenoisingDrug Design | —Unverified | 0 | 0 |
| Towards Unified AI Drug Discovery with Multiple Knowledge Modalities | Apr 17, 2023 | Drug DiscoveryKnowledge Graphs | —Unverified | 0 | 0 |
| Can LLMs Generate Diverse Molecules? Towards Alignment with Structural Diversity | Oct 4, 2024 | DiversityDrug Discovery | —Unverified | 0 | 0 |
| Emerging Opportunities of Using Large Language Models for Translation Between Drug Molecules and Indications | Feb 14, 2024 | Drug DiscoveryLanguage Modelling | —Unverified | 0 | 0 |
| Embracing Sex-specific Differences in Engineered Kidney Models for Enhanced Biological Understanding | Aug 29, 2023 | Drug DiscoveryKidney Function | —Unverified | 0 | 0 |
| A Perspective for Adapting Generalist AI to Specialized Medical AI Applications and Their Challenges | Oct 28, 2024 | Drug DiscoveryHallucination | —Unverified | 0 | 0 |
| Embracing assay heterogeneity with neural processes for markedly improved bioactivity predictions | Aug 17, 2023 | Drug DiscoveryMeta-Learning | —Unverified | 0 | 0 |
| Can Large Language Models Design Biological Weapons? Evaluating Moremi Bio | May 22, 2025 | Drug Discovery | —Unverified | 0 | 0 |
| Efficient nonmyopic batch active search | Dec 1, 2018 | DiversityDrug Discovery | —Unverified | 0 | 0 |
| Efficient nonmyopic active search with applications in drug and materials discovery | Nov 21, 2018 | Drug Discoveryscientific discovery | —Unverified | 0 | 0 |
| CandidateDrug4Cancer: An Open Molecular Graph Learning Benchmark on Drug Discovery for Cancer | Mar 2, 2022 | Drug DiscoveryGraph Learning | —Unverified | 0 | 0 |
| A parameterised model for link prediction using node centrality and similarity measure based on graph embedding | Sep 11, 2023 | Disease PredictionDrug Discovery | —Unverified | 0 | 0 |
| Efficient Nonmyopic Active Search | Aug 1, 2017 | Active LearningDrug Discovery | —Unverified | 0 | 0 |
| Efficient Fine-Tuning of Single-Cell Foundation Models Enables Zero-Shot Molecular Perturbation Prediction | Dec 18, 2024 | Drug DiscoveryZero-shot Generalization | —Unverified | 0 | 0 |
| Efficient Biological Data Acquisition through Inference Set Design | Oct 25, 2024 | Active LearningDrug Discovery | —Unverified | 0 | 0 |
| Efficient and Scalable Batch Bayesian Optimization Using K-Means | Jun 4, 2018 | Bayesian Optimizationcompressed sensing | —Unverified | 0 | 0 |
| Cancer Research UK Drug Discovery Process Mining | May 18, 2018 | Drug DiscoveryManagement | —Unverified | 0 | 0 |
| Economic impacts of AI-augmented R&D | Dec 15, 2022 | Deep LearningDrug Discovery | —Unverified | 0 | 0 |
| E(3)-invariant diffusion model for pocket-aware peptide generation | Oct 27, 2024 | Activity PredictionDrug Discovery | —Unverified | 0 | 0 |
| E3Bind: An End-to-End Equivariant Network for Protein-Ligand Docking | Oct 12, 2022 | Drug DiscoveryProtein Structure Prediction | —Unverified | 0 | 0 |
| Can AI Agents Design and Implement Drug Discovery Pipelines? | Apr 28, 2025 | AI AgentDrug Discovery | —Unverified | 0 | 0 |
| An unbiased metric of antiproliferative drug effect in vitro | May 22, 2016 | Drug Discovery | —Unverified | 0 | 0 |
| ABKD: Graph Neural Network Compression with Attention-Based Knowledge Distillation | Oct 24, 2023 | Drug DiscoveryFake News Detection | —Unverified | 0 | 0 |
| 3D pride without 2D prejudice: Bias-controlled multi-level generative models for structure-based ligand design | Apr 22, 2022 | Contrastive LearningDrug Discovery | —Unverified | 0 | 0 |
| E2CB2former: Effecitve and Explainable Transformer for CB2 Receptor Ligand Activity Prediction | Feb 15, 2025 | Activity PredictionDrug Design | —Unverified | 0 | 0 |
| Bures-Wasserstein Flow Matching for Graph Generation | Jun 16, 2025 | 3D Molecule GenerationDrug Discovery | —Unverified | 0 | 0 |
| Dumpling GNN: Hybrid GNN Enables Better ADC Payload Activity Prediction Based on Chemical Structure | Sep 23, 2024 | Activity PredictionDrug Discovery | —Unverified | 0 | 0 |
| Multi-View Graph Neural Networks for Molecular Property Prediction | May 17, 2020 | Drug DiscoveryGraph Neural Network | —Unverified | 0 | 0 |
| Bridging the gap between target-based and cell-based drug discovery with a graph generative multi-task model | Aug 9, 2022 | Drug Discovery | —Unverified | 0 | 0 |
| Antifragile and Robust Heteroscedastic Bayesian Optimisation | Sep 25, 2019 | Bayesian OptimisationDecision Making | —Unverified | 0 | 0 |
| DTI-SNNFRA: Drug-Target interaction prediction by shared nearest neighbors and fuzzy-rough approximation | Sep 22, 2020 | ClusteringDrug Discovery | —Unverified | 0 | 0 |
| Bridging the Fairness Divide: Achieving Group and Individual Fairness in Graph Neural Networks | Apr 26, 2024 | Drug DiscoveryFairness | —Unverified | 0 | 0 |
| DSDP: A Blind Docking Strategy Accelerated by GPUs | Mar 16, 2023 | Blind DockingDrug Discovery | —Unverified | 0 | 0 |